Cargando…

Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR‐338‐3p‐PKLR axis in hepatocellular carcinoma

Hormones and their corresponding receptors are vital in controlling metabolism under normal physiologic and pathologic conditions, but less is known about their roles in the metabolism of cancer. Using a small interfering RNA screening approach, we examined the effects of silencing 20 well‐known hor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Huizhen, Li, Jun, Yang, Xiao‐Mei, Cao, Qing‐Zhen, Feng, Ming‐Xuan, Xue, Feng, Wei, Lin, Qin, Wenxin, Gu, Jianren, Xia, Qiang, Zhang, Zhi‐Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Hepatobiliary Malignancies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755033/ https://www.ncbi.nlm.nih.gov/pubmed/26082033 http://dx.doi.org/10.1002/hep.27940

Ejemplares similares

Autophagy Suppresses Tumorigenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma Through Degradation of MicroRNA-224
por: Lan, Sheng-Hui, et al.
Publicado: (2014)

Down‐regulation of TIMP2 by HIF‐1α/miR‐210/HIF‐3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma
por: Kai, Alan Ka‐Lun, et al.
Publicado: (2016)

Dysregulated serum response factor triggers formation of hepatocellular carcinoma
por: Ohrnberger, Stefan, et al.
Publicado: (2015)

Evaluation of Abdominal Ultrasonography Mass Screening for Hepatocellular Carcinoma in Taiwan
por: Yeh, Yen-Po, et al.
Publicado: (2014)

World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
por: de Martel, Catherine, et al.
Publicado: (2015)

A Computed Tomography Radiogenomic Biomarker Predicts Microvascular Invasion and Clinical Outcomes in Hepatocellular Carcinoma
por: Banerjee, Sudeep, et al.
Publicado: (2015)

Immunodominance and functional alterations of tumor‐associated antigen‐specific CD8(+) T‐cell responses in hepatocellular carcinoma
por: Flecken, Tobias, et al.
Publicado: (2014)

Actin‐like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial‐mesenchymal transition
por: Xiao, Shuai, et al.
Publicado: (2016)

Signal transducer and activator of transcription 3‐mediated CD133 up‐regulation contributes to promotion of hepatocellular carcinoma
por: Won, Cheolhee, et al.
Publicado: (2015)

MAF1 suppresses AKT‐mTOR signaling and liver cancer through activation of PTEN transcription
por: Li, Yue, et al.
Publicado: (2016)

CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation–induced cell death in hepatocellular carcinoma
por: Lu, Guo-Dong, et al.
Publicado: (2015)

Hepatocellular carcinoma repression by TNFα‐mediated synergistic lethal effect of mitosis defect‐induced senescence and cell death sensitization
por: Li, Dan, et al.
Publicado: (2016)

MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors
por: Chuang, Kuang-Hsiang, et al.
Publicado: (2015)

MicroRNA-494 Within an Oncogenic MicroRNA Megacluster Regulates G(1)/S Transition in Liver Tumorigenesis Through Suppression of Mutated in Colorectal Cancer
por: Lim, Lionel, et al.
Publicado: (2014)

Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2
por: Liu, Runping, et al.
Publicado: (2014)

Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer
por: Aleksandrova, Krasimira, et al.
Publicado: (2014)

Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma
por: Andresen, Kim, et al.
Publicado: (2015)

Lineage-dependent effects of aryl hydrocarbon receptor agonists contribute to liver tumorigenesis
por: Harrill, Joshua A, et al.
Publicado: (2015)

The Linear ubiquitin chain assembly complex acts as a liver tumor suppressor and inhibits hepatocyte apoptosis and hepatitis
por: Shimizu, Yutaka, et al.
Publicado: (2017)

The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion
por: Liu, Jianwei, et al.
Publicado: (2023)

Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE
por: Bai, Shilei, et al.
Publicado: (2023)

TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma
por: Lima, Henrique A., et al.
Publicado: (2022)

Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: Sanoff, Hanna K., et al.
Publicado: (2016)

New concepts in the treatment of hepatocellular carcinoma
por: Sidali, Sabrina, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges
por: Liu, Xiufeng, et al.
Publicado: (2019)

Portal hypertension and hepatocellular carcinoma: Navigating uncharted waters
por: Sidali, Sabrina, et al.
Publicado: (2022)

Development of a Multivariate Prognostic Model for Lenvatinib Treatment in Hepatocellular Carcinoma
por: Li, Xiaomi, et al.
Publicado: (2023)

Dynamic contrast-enhanced CT and clinical features of sarcomatoid hepatocellular carcinoma
por: He, Guangming, et al.
Publicado: (2023)

Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance
por: Mähringer‐Kunz, Aline, et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review
por: Norero, Blanca, et al.
Publicado: (2023)

DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma
por: Zheng, Jing, et al.
Publicado: (2023)

Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma
por: Wei, Xiaolin, et al.
Publicado: (2023)

Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients
por: Owusu Sekyere, Solomon, et al.
Publicado: (2021)

Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
por: Müller, Lukas, et al.
Publicado: (2021)

High pretreatment static and dynamic alpha‐fetoprotein values predict reduced overall survival in hepatocellular carcinoma
por: Czauderna, Carolin, et al.
Publicado: (2021)

Contrast-enhanced ultrasound for screening hepatocellular carcinoma: an implemented program at a semi-rural academic center
por: Motz, Victoria L., et al.
Publicado: (2021)

Response evaluation of hepatocellular carcinoma treated with stereotactic body radiation therapy: magnetic resonance imaging findings
por: Mai, Zhijun, et al.
Publicado: (2023)

Neoadjuvant Treatment with Angiogenesis‐Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study
por: Woei‐A‐Jin, F.J. Sherida H., et al.
Publicado: (2021)

Real-world Treatment Patterns and Reasons for Therapy Selection in Patients with Advanced Hepatocellular Carcinoma in US Oncology Practices
por: Klink, Andrew J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7eceddgd23vqb6havo7la7ebc8